Genetically modified mosquitoes were released for the first time in the United States, taking flight in the Florida Keys in a pilot program intended to reduce the spread of deadly diseases such as dengue, yellow fever and the Zika virus.
Prior infection with dengue, a mosquito-borne disease that infects nearly 400 million people a year, could reduce the risk of contracting Zika nearly by half, U.S. and Brazilian researchers reported.
Japan’s Takeda Pharmaceutical Co. Ltd. said on Monday the U.S. Food and Drug Administration granted ‘fast track’ status to its vaccine for the mosquito-borne Zika virus.
A Zika vaccine Sanofi SA dropped during September 2017 under political pressure over pricing produced strong responses in more than 90 percent of those taking part in an early-stage clinical trial, U.S. researchers reported.
Japan’s Takeda Pharmaceutical moved ahead in the race to develop a vaccine for the mosquito-borne Zika virus, with the start of a clinical trial program backed by the U.S. government.
Texas launched aerial attacks on mosquitoes swarming coastal regions of the state and threatening to spread disease and hinder disaster recovery in the aftermath of Hurricane Harvey.
Austrian biotech company Themis Bioscience said it had started a clinical trial of an experimental Zika vaccine in healthy volunteers, opening up another front in the race to prevent the spread of the mosquito-borne disease.
U.S. Sen. Bernie Sanders is calling on President Donald Trump to carefully manage a deal between the U.S. Army and France-based pharma firm Sanofi to develop a Zika virus vaccine.
Adult women in Puerto Rico were significantly more likely to develop Zika than men, researchers said, raising new questions about the potential role of sexual transmission of the virus from males to females.
Health authorities in Colombia and Brazil will launch large-scale mosquito-control campaigns using a using naturally occurring bacteria known as Wolbachia.